Category: Include on Menu
-
Maze Therapeutics Shares Rise 2.9% After CIBC Initiates Coverage
Maze Therapeutics (NASDAQ:MAZE) shares rose 2.9% in pre-market trading after CIBC initiated coverage of the clinical-stage biopharmaceutical company with an Outperformer rating and a $50 price target. The move followed a decline of approximately 6.7% in Maze shares over the previous month. According to the source, the CIBC initiation brings the number of analysts with…
-
Verizon Commits $70 Million to Nationwide AI Training Initiative
Verizon (NYSE:VZ) said it is investing $70 million in a nationwide initiative aimed at providing artificial intelligence training to job seekers, small businesses and educators in the United States. The telecommunications company is working with non-profit organisations including Goodwill Industries and aims to provide AI training to hundreds of thousands of people. The initiative will…
-
Cracker Barrel Shares Rise 10% After Q4 Earnings Beat Estimates
Cracker Barrel Old Country Store, Inc. (NASDAQ:CBRL) shares rose 9.98% in pre-market trading on Wednesday after the restaurant chain reported fourth-quarter fiscal 2026 earnings and revenue above analyst expectations. Adjusted earnings per share for the quarter ended July 31, 2026, were $0.99, compared with the analyst consensus estimate of $0.10. Revenue was $849.3 million, above…
-
Sphere Entertainment and Disguise Sign Multi-Year Technology Partnership
Sphere Entertainment Co. (NYSE:SPHR) and visual technology company Disguise have entered into a multi-year partnership focused on developing technology for Sphere’s immersive entertainment venues. Disguise has provided media servers and software for the Sphere venue in Las Vegas since it opened in 2023, supporting live residency productions and corporate events. Under the expanded agreement, the…
-
AppLovin Shares Fall 3.5% as Edgewater Flags Slower Market Share Expansion
AppLovin (NASDAQ:APP) shares fell 3.5% after Edgewater Research analyst Joe Wittine said recent channel checks indicated that growth in the mobile advertising company’s market share metrics had slowed. Wittine forecast AppLovin’s fourth-quarter revenue growth at between 8% and 9% sequentially, below expectations he said had previously been reflected on Wall Street. According to the analyst,…
-
McDonald’s Sets 2030 Margin and Market Share Targets Under New Growth Strategy
McDonald’s Corporation (NYSE:MCD) has outlined a new long-term growth strategy, McDonald’s > NEXT, setting financial and operating targets through 2030 covering margins, restaurant efficiency, market share and systemwide sales. The company presented the strategy at an investor day at its Chicago headquarters on September 23, 2026. McDonald’s is targeting an operating margin in the low-to-mid…
-
Meta Expected to Unveil Camera-Free Smart Glasses at Connect
Meta Platforms (NASDAQ:META) is expected to introduce new smart glasses at its annual Connect conference on Wednesday, including models without cameras, as privacy issues surrounding wearable AI devices receive increased attention. According to The Information, Meta is expected to unveil two camera-free styles, known as Clubmaster and Burbank. The company has established a presence in…
-
General Mills Q1 Earnings Beat Estimates as Revenue Reaches $4.4 Billion
General Mills Inc. (NYSE:GIS) reported first-quarter adjusted earnings and revenue above analyst expectations while reaffirming its fiscal 2027 outlook. Adjusted earnings per diluted share were $0.75, compared with the consensus estimate of $0.72. Revenue was $4.4 billion, above expectations of $4.34 billion but down from $4.5 billion in the same period a year earlier. Net…
-
Roivant’s Immunovant Stops IMVT-1402 Development in Cutaneous Lupus After Trial Miss
Roivant Sciences (NASDAQ:ROIV) said its majority-owned subsidiary Immunovant will discontinue development of IMVT-1402, also known as imeroprubart, in cutaneous lupus erythematosus after a proof-of-concept study failed to meet its primary endpoint. The randomised, double-blind, placebo-controlled trial enrolled 57 adults with cutaneous lupus erythematosus. Its primary endpoint measured the percentage change from baseline in the Cutaneous…
-
Beneficient Seeks Resolution to Eliminate About $130 Million of Disputed Debt Linked to Former CEO
Beneficient (NASDAQ:BENF) said it is seeking an agreement with former Chief Executive Officer Brad Heppner that would eliminate approximately $130 million of disputed debt and restructure his remaining equity and contractual interests in the company. Heppner was convicted on May 7, 2026, of federal charges including securities fraud and wire fraud. According to Beneficient, evidence…